Business transfers

Jan 2023

Virtualis joins Demant: virtual reality for the treatment of vertigo and functional rehabilitation.

Customers and counterparties

This acquisition allows Demant to expand its offer in functional rehabilitation and vertigo. With Demant’s entry into the company’s capital as a majority shareholder, Virtualis will be able to draw on the international scope of one of the world’s leading hearing aid companies to extend its geographical reach, establish its reputation and pursue its development.

Virtualis, the French medtech company, and world leader in virtual reality applications for healthcare, has chosen the Danish group Demant – the world leader in hearing aids listed on the Nasdaq in Copenhagen – to accompany it in its entrepreneurial adventure. This acquisition of a stake in Demant’s capital will enable Virtualis to be backed by a heavyweight in the sector. Demant will accelerate its international deployment by leveraging its global distribution network, its industrial capacity, and its worldwide technical support and installation teams.

We are particularly proud to have been joined by the Demant Group in our great adventure. This collaboration will allow us to develop internationally and promote our growth while maintaining our DNA and our team. The support provided by Pax Corporate Finance and the PGA team enabled us to carry out this transaction calmly and confidently, with the certainty that our interests were being defended in good faith. Franck Assaban
PAX teams were pleased to support Franck Assaban and his teams, designers of cutting-edge French solutions combining virtual reality and artificial intelligence for the benefit of global health. Several leading groups have shown a strong interest in Virtualis, leading to a landmark transaction for the medical sector. Adrien Tourres

Associate members